26 August 2010
| Take advantage of the summer discount |
 
Deadline for discount: September, 21
To claim your offer,
enter “Special
Summer Discount” in the “Comments”
box of the registration
form
for the second delegate.
Follow the example of many major actors who already registered:
Abbott, Ablynx, Ascenion, AstraZeneca, AUTM, Burrill&Company, DSM,
GE Healthcare, Galapagos, Genfit, Ghent University, GSK, Johnson&Johnson,
Laboratoires Servier, LFB, Merck & Co, Merck Serono, Norgine, Pharmivation Limited, Pfizer, Sanofi,
Queen Mary Institute, UCB,
Technion T3, Wellcome Trust, etc.
View the preliminary list of participating companies |
 |
| One event for 3 activities |
Biofit is a tremendous and unique tech transfer partnering event, that brings together research teams, companies and investors to foster collaborative R&D projects
Pre-screened one-to-one meetings between academia, start ups, finance and pharma.
Over 350 key players of innovation in the life sciences sector will come together to explore successful public-private partnerships. During the two-day event allowing numerous pre-arrange one-to-one meetings, academics, industry stakeholders and CEO entrepreneurs will share best practices and initiate technology transfer and collaborative projects.
Read more and register
The meetings are powered by  which is the leading conference partnering solution for the life sciences. Combining the industry’s most advanced collaboration software with best practice implementation, partneringONE ensures that Biofit will be a world-class partnering event.
Read more |
Meet the 35 prestigious speakers during the 8 session panels of the Biofit conference program!
Sponsored by  |
Both the academia and the industry are currently showing a growing interest in collaborative projects while the public-private collaboration is increasingly stimulated through national and international funding schemes. It was time to conceive a new event to deal with these issues – and to present some explanations and advices to make the most of them.
Our experts will share their experience and expertise to explore hands-on approaches to help the different actors of the life sciences sector creating win-win partnerships. Theory and practice will be associated to provide answers to the emerging issues of collaborative projects offered by the development of Open Innovation
Read more
| Presenting technologies and companies |
from cutting edge public and private research laboratory
In partnership with 
IP asset management company focused on the life sciences |
Two categories - Two opportunities
 Presenting technologies tracks for academic researchers, TTOs and scientific directors from innovative companies looking for research collaboration and tech transfer opportunities.
During two days, presentations will combine 15-min talk and 5-min Q&A covering various therapeutic areas
Presenting companies tracks for IP & law firms, services providers, consulting companies seeking for business with high potential academia and companies.
Read more and apply
|
Who should attend Biofit?
 R&D, licensing and business development managers
Technology transfer officers
Public and private laboratory directors
Investors
Public organizations supporting innovation |
Major sponsor
 |
Silver sponsor
 |
Silver sponsor
 |
Silver sponsor
 |
Contributing sponsors
 |
Contributing sponsors
 |
Conference program sponsor
|
|
Why joining in?
Some participants who already registered explain : |
"My expectations from BioFIT 2010 ? Great networking, inspiring presentations, great discussions about Open Innovation, successful innovative partnering...and why not : meeting UCB's next business partner !"
Patrice Talaga, Director Chemistry Outsourcing, UCB (Belgium) |
“While BioFIT provides that famous French hospitality in a user-friendly facility, it also promises to be a truly international conference.”
Garold Breit, Executive Director,Technology Transfer Office of the University of Manitoba, (Canada) |
"There are few places where academia, industry and other interested players come together to share perspectives in the absence of the pressure of direct deal negociations: Biofit 2010 is such an occasion”
Kari Paukkeri, Chief Executive Officer, Licentia Ltd. (Finland) |
|
“Precompetitive collaboration between academia, biotech and big pharma, and moving towards models of open innovation are a “conditio sine qua non” for Europe’s health care industry’s future.”
Ludo Lauwers, Senior VP and Beerse Site Manager, Johnson and Johnson Pharmaceuticals R&D (Belgium) |
"With the right size and the right people, I expect from BioFIT 2010 a very personal venue offering opportunities to engage in productive partnering discussions"
Lucienne Cicurel, Director External Affairs, Debiopharm Group (Switzerland) |
Two days of productive partnering and a cutting-edge conference program at moderate price!
|
